Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we learn more about AlphaGenome’s efforts to unravel DNA dark matter, read about a new AI-driven biotech backed by former Google CEO Eric Schmidt, and more. Summit Therapeutics said the FDA accepted its application seeking approval of its PD-1/VEGF antibody ivonescimab to treat non-small cell lung cancer. AstraZeneca plans to invest $15 billion in China through 2030 to expand its manufacturing and R&D capabilities.